ClinConnect ClinConnect Logo
Search / Trial NCT05965362

Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR)

Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Jul 20, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Infective Endocarditis Prognosis Major Adverse Cardiac And Cerebrovascular Event

ClinConnect Summary

The ENDEAVOR trial is a research study focused on understanding the condition known as infective endocarditis, which is an infection of the inner lining of the heart. Researchers aim to learn more about how this disease progresses and what factors can influence patient outcomes. By analyzing various biological markers in patients, they hope to discover new insights that could improve diagnosis and treatment options for those affected by this condition.

To participate in this study, candidates must have a confirmed diagnosis of infective endocarditis. Unfortunately, those who cannot provide consent or who have serious other health issues that prevent them from providing biological samples will not be eligible. Participants can expect to contribute to important research that might help shape future care for patients with infective endocarditis. The study is currently recruiting individuals and welcomes patients of all genders aged 65 and older.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with clinically confirmed infective endocarditis
  • Exclusion Criteria:
  • Patients refuse to sign informed consent form
  • Patients who combined with serious systemic diseases, cannot tolerate the acquisition of biological samples

About First Affiliated Hospital Xi'an Jiaotong University

The First Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution renowned for its commitment to advancing healthcare through clinical research and innovative treatment approaches. As a prominent academic hospital in China, it integrates clinical practice, education, and research, fostering a collaborative environment that enables the development of cutting-edge therapies and medical technologies. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital plays a pivotal role in conducting high-quality clinical trials that aim to improve patient outcomes and contribute to the global medical community.

Locations

Xi'an, Shaanxi, China

Patients applied

0 patients applied

Trial Officials

Yang Yan

Principal Investigator

First Affiliated Hospital Xi'an Jiaotong University

Guoliang Li

Principal Investigator

First Affiliated Hospital Xi'an Jiaotong University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported